|
⚲
|
| Keyboard |
| Cortexyme Inc
✚
|
|
|---|---|
| CIK # | 0001662774 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001662774] | |
| 10-Q | [0001662774] | |
| 3 | [0001662774] | |
| 4 | [0001662774] | |
| 5 | [0001662774] | |
| 8-K | [0001662774] | |
| D | [0001662774] | |
| SC 13D | [0001662774] | |
| SC 13G | [0001662774] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Quince Therapeutics Inc QNCX
Employee Stock Option (Right to Buy) · derivative
|
2026-01-23 | Grant | 200,000 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Employee Stock Option (Right to Buy) · derivative
|
2026-01-23 | Grant | 1,000,000 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Employee Stock Option (Right to Buy) · derivative
|
2026-01-23 | Grant | 365,000 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 18,724 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 19,547 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 21,810 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 29,423 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2025-12-26 | Sell | 50,000 | $3.47 | 173,500 |
|
Quince Therapeutics Inc QNCX
Common Shares
|
2025-12-10 | Gift | 739,885 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Common Shares
|
2025-12-10 | Gift | 739,885 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Employee Stock Option (Right to Buy) · derivative
|
2025-12-05 | Option exercise | 25,280 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Common Shares
|
2025-12-05 | Option exercise | 25,280 | $0.94 | 23,763 |
|
Quince Therapeutics Inc QNCX
Common Shares
|
2025-12-05 | Option exercise | 2,271 | $0.55 | 1,249 |
|
Quince Therapeutics Inc QNCX
Employee Stock Option (Right to Buy) · derivative
|
2025-12-05 | Option exercise | 2,271 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Warrants · derivative
|
2025-06-18 | Grant | 37,736 | $0.13 | 4,906 |
|
Quince Therapeutics Inc QNCX
Common Shares
|
2025-06-18 | Grant | 37,736 | $1.20 | 45,283 |
|
Quince Therapeutics Inc QNCX
Common Shares
|
2025-06-18 | Grant | 7,548 | $1.20 | 9,058 |
|
Quince Therapeutics Inc QNCX
Common Shares
|
2025-06-18 | Grant | 150,944 | $1.20 | 181,133 |
|
Quince Therapeutics Inc QNCX
Warrants · derivative
|
2025-06-18 | Grant | 7,548 | $0.13 | 981 |
|
Quince Therapeutics Inc QNCX
Warrants · derivative
|
2025-06-18 | Grant | 150,944 | $0.13 | 19,623 |
| showing 20 of 200 most recent transactions | |||||